279 related articles for article (PubMed ID: 24014303)
1. miR deregulation in CLL.
Balatti V; Pekarky Y; Rizzotto L; Croce CM
Adv Exp Med Biol; 2013; 792():309-25. PubMed ID: 24014303
[TBL] [Abstract][Full Text] [Related]
2. Role of microRNA in chronic lymphocytic leukemia onset and progression.
Balatti V; Pekarky Y; Croce CM
J Hematol Oncol; 2015 Feb; 8():12. PubMed ID: 25886051
[TBL] [Abstract][Full Text] [Related]
3. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of CLL.
Pekarsky Y; Zanesi N; Croce CM
Semin Cancer Biol; 2010 Dec; 20(6):370-6. PubMed ID: 20863894
[TBL] [Abstract][Full Text] [Related]
5. Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia.
Sivina M; Hartmann E; Vasyutina E; Boucas JM; Breuer A; Keating MJ; Wierda WG; Rosenwald A; Herling M; Burger JA
Leukemia; 2012 Aug; 26(8):1812-20. PubMed ID: 22460735
[TBL] [Abstract][Full Text] [Related]
6. TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia.
Balatti V; Rizzotto L; Miller C; Palamarchuk A; Fadda P; Pandolfo R; Rassenti LZ; Hertlein E; Ruppert AS; Lozanski A; Lozanski G; Kipps TJ; Byrd JC; Croce CM; Pekarsky Y
Proc Natl Acad Sci U S A; 2015 Feb; 112(7):2169-74. PubMed ID: 25646413
[TBL] [Abstract][Full Text] [Related]
7. Is miR-29 an oncogene or tumor suppressor in CLL?
Pekarsky Y; Croce CM
Oncotarget; 2010 Jul; 1(3):224-7. PubMed ID: 20936047
[TBL] [Abstract][Full Text] [Related]
8. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia.
Calin GA; Pekarsky Y; Croce CM
Best Pract Res Clin Haematol; 2007 Sep; 20(3):425-37. PubMed ID: 17707831
[TBL] [Abstract][Full Text] [Related]
9. Novel insights in molecular mechanisms of CLL.
Zanesi N; Balatti V; Bottoni A; Croce CM; Pekarsky Y
Curr Pharm Des; 2012; 18(23):3363-72. PubMed ID: 22591386
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
[TBL] [Abstract][Full Text] [Related]
11. Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
Zhu DX; Miao KR; Fang C; Fan L; Zhu W; Zhu HY; Zhuang Y; Hong M; Liu P; Xu W; Li JY
Leuk Res; 2011 Jun; 35(6):730-4. PubMed ID: 21130495
[TBL] [Abstract][Full Text] [Related]
12. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
[TBL] [Abstract][Full Text] [Related]
13. Chronic lymphocytic leukemia: molecular genetics and animal models.
Pekarsky Y; Calin GA; Aqeilan R
Curr Top Microbiol Immunol; 2005; 294():51-70. PubMed ID: 16323427
[TBL] [Abstract][Full Text] [Related]
14. Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL).
Hanlon K; Rudin CE; Harries LW
PLoS One; 2009 Sep; 4(9):e7169. PubMed ID: 19779621
[TBL] [Abstract][Full Text] [Related]
15. Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia.
Lin K; Farahani M; Yang Y; Johnson GG; Oates M; Atherton M; Douglas A; Kalakonda N; Pettitt AR
Br J Haematol; 2014 Nov; 167(3):346-55. PubMed ID: 25040181
[TBL] [Abstract][Full Text] [Related]
16. miR-15 and miR-16 induce apoptosis by targeting BCL2.
Cimmino A; Calin GA; Fabbri M; Iorio MV; Ferracin M; Shimizu M; Wojcik SE; Aqeilan RI; Zupo S; Dono M; Rassenti L; Alder H; Volinia S; Liu CG; Kipps TJ; Negrini M; Croce CM
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13944-9. PubMed ID: 16166262
[TBL] [Abstract][Full Text] [Related]
17. Novel mechanisms of regulation of miRNAs in CLL.
Balatti V; Acunzo M; Pekarky Y; Croce CM
Trends Cancer; 2016 Mar; 2(3):134-143. PubMed ID: 27213184
[TBL] [Abstract][Full Text] [Related]
18. Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene PLAG1 by deregulated miRNAs.
Patz M; Pallasch CP; Wendtner CM
Leuk Lymphoma; 2010 Aug; 51(8):1379-81. PubMed ID: 20687796
[TBL] [Abstract][Full Text] [Related]
19. The role of the genetic abnormalities, epigenetic and microRNA in the prognosis of chronic lymphocytic leukemia.
Tari K; Shamsi Z; Reza Ghafari H; Atashi A; Shahjahani M; Abroun S
Exp Oncol; 2018 Dec; 40(4):261-267. PubMed ID: 30593759
[TBL] [Abstract][Full Text] [Related]
20. Role of microRNAs in Chronic Lymphocytic Leukemia Pathogenesis.
Javandoost E; Firoozi-Majd E; Rostamian H; Khakpoor-Koosheh M; Mirzaei HR
Curr Med Chem; 2020; 27(2):282-297. PubMed ID: 31544709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
